Lead Change Blog

JULY 6, 2015

The second example, from a pharmaceutical company, states their purpose is “to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.” They discover, develop, and deliver innovative medicines. There is no clarity here. ” What does this company do? For whom do they do it?

Pharmaceuticals 150

Pharmaceuticals Discount Cooper Tactics 150

Michael Lee Stallard

SEPTEMBER 16, 2015

Pfizer, the multinational pharmaceutical giant, has become increasingly intentional about shaping its culture. They embody our humanity and innovative spirit, and are determined to tackle some of the most pressing health care challenges of our time. Developing this ownership culture will be key to our success. Pfizer people care.

Ethics 150

Ethics Pharmaceuticals Globalization Commitment 150

HR Digest

NOVEMBER 9, 2021

The HR Digest talked to Quita Highsmith to discuss the essential role of HR in building a culture of agility, innovation, and engagement. We believe that diversity is more than good for business – it’s good for scientific innovation. The HR Digest: What are the non-negotiable parts of Genentech’s company culture?

Pharmaceuticals 52

Pharmaceuticals Industry Diversity Career 52

Mills Scofield

NOVEMBER 19, 2013

My twelve hours at the conference was an unbelievably stimulating torrent of inspiration, passion, and elegance that began with the gorgeous piece by a 13 th generation Noh performer and continued with a series of Japanese and foreign speakers giving talks on their incredibly innovative work and honest personal stories.

Conference 126

Conference Pharmaceuticals Education Brainstorming 126

Marshall Goldsmith

FEBRUARY 24, 2014

Every company wants “integrity,” “respect for people,” “quality,” “customer satisfaction,” “innovation,” and “return for shareholders.” When I conducted leadership training for J&J, one of its very top executives spent many hours with every class.

Ethics 137

Ethics Pharmaceuticals PR Execution 137

Lead on Purpose

SEPTEMBER 8, 2009

Over 150 companies, including Durkee, Cremora, San Giorgio, Ronzoni, and McCormick, now use the entire line of Flapper products, and Weatherchem continues to lead the industry in offering the widest, most innovative array of closure products. Filed under: Integrity , Leadership , Purpose , Team Building , Trust Tagged: | Albert J.

Committee 140

Committee Automotive Ethics Products 140

Tanveer Naseer

MARCH 10, 2015

The following is a guest piece by Innovation Excellence co-founder Rowan Gibson. What most companies understand now is that the only way to drive profitable growth and wealth creation over the longer term is to innovate. But that’s not the way radical innovators envisage their organizations. This is quite understandable.

How To 100

How To Retail Core Competence Innovation 100

The Horizons Tracker

SEPTEMBER 21, 2023

What you really do need is knowledge of that specific industry, whether it’s pharmaceutical or manufacturing or hospitality or rocket science.” However, the research suggests that exploring external CEO options could be a proactive strategy for firms seeking to enhance their performance and leadership.

Press Release 119

Press Release CEO Pharmaceuticals Industry 119

The Horizons Tracker

MAY 2, 2023

. “Here again, we refer to the stakeholders and the business model in this industry: the trade sector is dominated by small and medium-sized firms that are engaged in the wholesale and retail sale of household goods (largest share in our sample), furniture, plumbing, pharmaceutical goods, and so on,” the researchers explain.

Class 129

Class CEO Education Engineering 129

Coaching Tip

MARCH 15, 2011

All it takes is the desire to be innovative and creative in tackling a problem. Al Weatherhead is the author of The Power Of Adversity and chairman and CEO of Weatherchem, a private manufacturer of plastic closures for food, spice, pharmaceutical and nutraceutical products. Entrepreneurship.

Pharmaceuticals 84

Pharmaceuticals Creativity Long-term Power 84

Strategy Driven

JULY 13, 2011

Medium-term value drivers look forward to indicate whether a company can maintain and improve its revenue growth and ROIC over the next one to five years (or longer for companies, such as pharmaceutical manufacturers, that have long product cycles). As with the other measures, what is important varies by industry.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

The Horizons Tracker

FEBRUARY 22, 2022

billion and is estimated to be worth $48 billion by 2026, with the Covid pandemic driving growth, especially in the healthcare and pharmaceutical industries, but also in sectors such as automotive and defense. It’s a market that is already worth $3.1

Stephenson 114

Stephenson Wireless Christensen Automotive 114

Strategy Driven

DECEMBER 13, 2018

It was inconceivable to him that a leadership team could have fun together. A few years back, I coached a national pharmaceutical team with distinct geographies. Drawing from his own extensive background and 10 years of research, Douglas innovated the concept of “Team Quotient” (TQ). How can we have fun? This is business!”

Team 58

Team Pharmaceuticals Project Learning-by-Doing 58

Strategy Driven

JANUARY 24, 2011

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

FEBRUARY 22, 2011

Editor's note: This post is the first in a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. Lack of consensus among players in a complex system is one of the biggest barriers to innovation. It's a classic change management problem.

Health Care 16

Health Care Innovation Pharmaceuticals Consensus 16

Harvard Business Review

SEPTEMBER 23, 2014

I often hear this question when I visit companies and speak about how to make an innovative idea less terrifying to high level executives. There are plenty of pundits arguing that big companies need to innovate, and pointing out that it is difficult to do so. Have you actually seen this done?”. The skepticism is warranted.

Innovation 14

Innovation P&L Short-term Company 14

Harvard Business Review

OCTOBER 11, 2013

Four years ago, Craig Hatkoff, co-founder of the Tribeca Film Festival, approached me about a brainstorm: an event recognizing and celebrating breakthrough innovators. When I suggested to Clayton Christensen that we partner with Hatkoff to create the Tribeca Disruptive Innovation Awards , Clay’s response was : I trust you Whitney.

Innovation 14

Innovation Christensen Decisionmaking CTO 14

Harvard Business Review

MARCH 11, 2018

That rule of life is no secret to pharmaceutical companies across the globe. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. “Japanese leaders recognize the importance of encouraging medical innovation,” Eli Lilly and Co. Older people need more medicine.

Pharmaceuticals 9

Pharmaceuticals Health Care Industry Content 9

Harvard Business Review

OCTOBER 6, 2016

Investments in traditional leadership development are often misguided and a waste of money. In a Deloitte study of 7,000 organizations this year, 89% of executives rated “ strengthening the leadership pipeline ” an urgent issue. The culture at GE, for example, centers on execution, simplicity, and innovation.

Leadership Pipeline 16

Leadership Pipeline Leadership After Action Review Pharmaceuticals 16

Harvard Business Review

MARCH 14, 2017

For industries that depend on innovation, sustaining it is a constant challenge. These two actions cost almost nothing compared to vast sums often spent — and arguably, often wasted — on efforts to foster innovation. However, these prescriptions for innovation at Roivant have also led to some unexpected challenges.

Innovation 14

Innovation Company Incentives Industry 14

Harvard Business Review

OCTOBER 29, 2012

If the cost of innovation is falling, that should enable more of it from poorer countries, companies or cooperatives. If it's not, the already big and already rich will dominate innovation. Some of this may just be the product of the high regulatory costs in pharmaceuticals, but research by Harvard's F.M.

Cost 10

Cost Innovation Wireless Disruptive Innovation 10

Harvard Business Review

FEBRUARY 21, 2012

Having a strong domestic manufacturing base is vital to the United States maintaining its world leadership in innovation. The best factories routinely conduct scientific experiments to improve their processes, and the best factory managers are teachers and innovators as well as leaders of people.

Supply Chain 16

Supply Chain Offshoring Engineering Pharmaceuticals 16

Harvard Business Review

JUNE 16, 2011

So it is with most breakthrough innovations and banner financial years. There is no line on the balance sheet for "ability to innovate" or "skill at managing brand." And even if there were, it would have to be expressed as a probability statement: How likely is Apple to innovate or out-innovate its peers?

Intangible Assets 16

Intangible Assets Analysis Pharmaceuticals Innovation 16

Harvard Business Review

MARCH 1, 2011

Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. And that's true in many areas: New devices, pharmaceuticals, and surgical techniques regularly get developed and incorporated into practice.

Health Care 15

Health Care Biotechnology Mayo Pharmaceuticals 15

Strategy Driven

MARCH 18, 2011

Those companies that ‘sweat’ their capabilities continuously improve them and sustainably capture the top-line growth in their industries and, ultimately, market leadership. First is an effectiveness benefit, which is realized simply in doing what you’re exceptionally good at over and over, day in and day out.

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

SEPTEMBER 4, 2015

Innovation is widely regarded as important to long-term business performance. We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Overall, it is a messy picture.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

MARCH 8, 2011

Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. For example, Sproxil has found pharmaceutical buyers for its anti-drug counterfeiting service. There are now more than 5.3

Wireless 16

Wireless Health Care Pharmaceuticals Business Model 16

Harvard Business Review

OCTOBER 18, 2012

People of color too often feel that they have to hide their true selves at work, according to "Vaulting the Color Bar: How Sponsorship Levers Multicultural Professionals into Leadership," a new research report from the Center for Talent Innovation.

Pharmaceuticals 20

Pharmaceuticals Diversity Uncertainty Focus Group 20

Harvard Business Review

JUNE 23, 2016

A global pharmaceutical company was about to lose the strategic advantage of several blockbuster drugs coming off patent. That, in brief, is the concept of a leadership circle. In short, today’s existing leadership structure, expertise and purpose are designed to address today’s challenges — not tomorrow’s.

Leadership 14

Leadership Diversity Committee Long-term 14

Harvard Business Review

MARCH 2, 2012

Here at Harvard Business School, Dean Nitin Nohria has revamped HBS's MBA curriculum to emphasize practical leadership and global experiences. American companies send their most promising leaders abroad for global leadership assignments. America fosters risk-taking and innovation by entrepreneurs who become global leaders.

Competitive Advantage 16

Competitive Advantage Globalization Development Intellectual Capital 16

Harvard Business Review

OCTOBER 7, 2014

The lesson: Frontline people can not only help the top leader validate an innovative new strategy, they can also be a powerful means to convince customers and those in higher levels at your company to buy in. . One day he observed a pharmaceuticals sales rep stop the car and run into a Costco for a few minutes. That’s pivotal.

CEO 14

CEO Strategy Pharmaceuticals B2B 14

Harvard Business Review

APRIL 13, 2012

It's depressing to realize how few of the teams in our lives use their human capital and opportunities well, when it comes to sustaining performance, innovating, or adapting. Balancing these tensions requires resonant leadership. Resonant leadership and social identity groups do this. Now to the world of business.

Team 18

Team Sports Pharmaceuticals PR 18

Harvard Business Review

MAY 8, 2013

I recently conducted a study of 56 randomly selected companies involved in major change and innovation efforts in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries. Nearly 68% of these large-scale change and innovative efforts failed.

Middle Management 11

Middle Management Management Automotive Pharmaceuticals 11

Harvard Business Review

DECEMBER 27, 2016

Doctors were once viewed as ill-prepared for leadership roles because their selection and training led them to become “heroic lone healers.” The emphasis on patient-centered care and efficiency in the delivery of clinical outcomes means that physicians are now being prepared for leadership. ” But this is changing.

Management 15

Management 360-Degree Feedback Mayo Training 15

Harvard Business Review

JUNE 20, 2017

For organizations seeking to become more adaptive and innovative, culture change is often the most challenging part of the transformation. Innovation demands new behaviors from leaders and employees that are often antithetical to corporate cultures, which are historically focused on operational excellence and efficiency.

Company 16

Company Agility Innovation Learning-by-Doing 16

Harvard Business Review

OCTOBER 27, 2014

I studied large-scale change and innovation efforts in 56 randomly selected companies in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries. Change management Execution Leadership' My research found that the majority of the efforts failed.

Middle Management 19

Middle Management Six Sigma Taylorism Taylor 19

Harvard Business Review

APRIL 22, 2013

Most of us think of biotech as the province of multinational pharmaceutical corporations and well-funded ventures, but the founders of BioCurious believe (as they say in their mission statement) "that innovations in biology should be accessible, affordable, and open to everyone." Socialize your underused assets.

Mission Statement 13

Mission Statement Class Learning-by-Doing Pharmaceuticals 13